Industry News
- Biogen shareholders: CEO pay 'inconsistent' with poor stock performance
- Corindus raises $4.7M in equity funds
- CambridgeSoft's private financing worth $31M
- Second license deal with Amgen to bring ImmunoGen another $35M
- Boston Heart Lab pumped with new funds, jobs, office space
- Medical device firms show cautiously optimistic outlook
- German biotech Caprotec opens Burlington subsidiary
- Genzyme halts kidney treatment development
- ACT seeks FDA OK for stem cell study to treat blindness
- Biotech startup Ligon Discovery attracts $1M in VC funds
- Athena Diagnostics slaps IP suit on Calif. genetics firm
- Pressure BioSciences closes $1.2M tranche
- Clinical Data’s cardiac stress test hits Phase 3 trials
- Knome targets researchers with new genomic service
- Clinical Data names scientific board
- Advanced BioHealing begins skin substitute trial
- Alkermes moves alcohol dependency drug candidate to Phase 2 study
- UNH professors win $1.4M in NSF grants
- Life sciences software maker CambridgeSoft takes in more funds
- FDA rejects Genzyme’s Pompe disease drug again
- ACT closes $15M private placement
- Humedica forms scientific advisory board
- Alkermes to push opioid dependence treatment for FDA approval
- Putney pulls in $6.7M, plans growth
- Five Genzyme drugs contaminated; stock plummets
- Echo Therapeutics gets $3M from private placement
- Thermo Fisher refinances debt
- Biotech, pharma foresee higher costs from House health reform bill
- Cequent files first IND application
- Novelos closes $9M private placement
- Cambridge Heart partners with Cardiac Science
- Altus files for Ch. 7 bankruptcy
- Generex Biotechnology granted extension for Nasdaq compliance
- Metabolix makes $27M public offering
- Aponos wins WPI Venture Forum Business Plan Contest
- Vertex exchanges notes for company stock
- Helicos ends acquisition talks
- Inverness ends Thermo distribution deal
- BioTrove poised for acquisition, new spin-out
- Ironwood to net $75M from licensing deal in Japan
- Pfizer R&D vet LaMattina joins PureTech Ventures
- BioVex boosts Series F to $70M to move cancer treatment forward
- Concert Pharmaceuticals to land $12M from HIV drug's clinical study
- GTC Biotherapeutics execs land retention pay amid layoffs
- Covidien nearly completes Aspect acquisition
- Caliper to ID toxic chemicals with $1.8M EPA contract
- Microfluidics dealt $1M credit line
- Boston Scientific pays $296M to settle Guidant allegations
- Gloucester Pharmaceuticals’ lymphoma drug wins FDA OK
- Beerman takes CEO post at RXi Pharmaceuticals
- Facet Solutions acquires Archus Orthopedics
- N.E. researchers share grants for infectious diseases
- PerkinElmer newborn screening platform gets FDA clearance
- Shire's Gaucher drug gets FDA priority review
- Health IT firm Quantros opens Marlborough office, plans new hires
- Medical device firm Facet Solutions pulls in $3.6M
- Pro-Pharmaceuticals grabs another piece of $6M funding round
- Synta sees profit gain on broken GSK deal
- Job cuts help CombinatoRx narrow Q3 loss
- Werner Schaefer joins Neuroptix board
- Alnara appoints chief medical officer Brettman
- SV Life Sciences appoints new partners Ryan and Wachtman
- J&J to cut 7,000; Mass. impact unclear
- Genzyme manufacturing plant gets EU OK
- Personalized cancer therapy firm On-Q-ity lands $21M
- Boston Scientific stent gets European approval
- Insulet aims for $61.5M public stock offering
- Seaside launches trial for autism treatment
- RNAi startup Cequent raises $3.4M
- GTC Biotherapeutics pulls in $10M from shareholder
- Pulmatrix lands $32M in multiple fundings
- Foley & Lardner wins $208M NIH IP contract
- Lab equipment maker Bruker sees spike in shares
- Javelin Pharma attracts $3.9M stock offer
- PerkinElmer Q3 earnings show promising outlook
- Third Rock rests VC hopes in rare genetic disease treatments
- Celldex cancer drug candidate returns positive news
- CorNova lands $2.5M in financing
- Framingham wastewater collection nets $7.7M from MLSC
- Virdante Pharmaceuticals boosts first round to $47M
- Stryker Biotech indicted in deceit scheme
- Interlace device lands FDA clearance
- MIT grant applies physics to cancer research
- Excelimmune wins SBIR grant
- Vertex Pharma sees wider Q3 loss
- Environmental lab Alpha Analytical buys Boston Analytical
- Aiko opioid painkiller returns positive trial results
- Inverness sees Q3 revenue uptick
- Helicos considers ‘strategic alternatives’
- Thermo Fisher launches heart attack biomarker in Europe
- Positive results for Antigenics' brain cancer therapy
- American Well pulls in $10M for online doctor visits
- Cephalon pays $30M for option to buy BioAssets
- Biogen shares tumble on more MS drug-linked infections
- Molecular Insight signs global cancer therapy deal
- Biocell Center opens amniotic stem cell bank in Medford
- Nuclea wraps up $3.4 million funding
- Synta's failed drug target may be reborn from biomarker discovery
- Lawrence General Hospital: A beacon of e-health success
- Allegro Diagnostics lands $2.8M SBIR grant for lung cancer diagnostics
- Thermo Fisher Q3 revenue falls, net income up on cost cuts
- GE launches $250M healthcare IT fund
- Genzyme Q3 net income plummets amid plant shutdown woes
- Genzyme moves oral Gaucher disease drug to Phase 3 trials
- Sepracor buyout completed; CEO Adams to receive up to $11M
- Cambridge Consultants touts innovation, launches e-health device
- Seventh Sense Biosystems' malaria monitoring project wins Gates Foundation grant
- Biogen Q3 net income, revenue increase
- UMass Medical School taps Ware for better patient data tools
- Boston Scientific stock falls after lower guidance
- Aileron Therapeutics appoints Kafka as CFO
- Synageva closes newly increased $45M investment
Friday, November 20, 2009
Thursday, November 19, 2009
Wednesday, November 18, 2009
Tuesday, November 17, 2009
Monday, November 16, 2009
Friday, November 13, 2009
Thursday, November 12, 2009
Wednesday, November 11, 2009
Tuesday, November 10, 2009
Monday, November 9, 2009
Friday, November 6, 2009
Thursday, November 5, 2009
Wednesday, November 4, 2009
Tuesday, November 3, 2009
Monday, November 2, 2009
Friday, October 30, 2009
Thursday, October 29, 2009
Wednesday, October 28, 2009
Tuesday, October 27, 2009
Monday, October 26, 2009
Friday, October 23, 2009
Thursday, October 22, 2009
Wednesday, October 21, 2009
Tuesday, October 20, 2009
RSS Feeds
